CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Cancer Network
Original article

<![CDATA[Emerging CELMoDs in Multiple Myeloma]]>

Trial StartcemsidomideNeutral
AI Analysis

Summary

Discussion of emerging CELMoD agents in multiple myeloma, focusing on the investigational drug cemsidomide and the ongoing MOMENTUM trial.

Clinical Trial Data

Importance:2/10
Sentiment:
0.00
CELMoDmultiple myelomacemsidomideMOMENTUM trialinvestigational

Read the original article

Published by Cancer Network on September 14, 2026 12:00 PM

Read Original